Forbion
Naarden, Netherlands
Venture capitalSeedSeries ASeries BGrowth
- Ticket size
- Not published
- Activity
- Last deal November 2026
About
Global venture capital firm investing in biotech and sustainable solutions for human and planetary health; EUR 7.5bn across 13 funds.
- Headquarters
- Naarden, Netherlands
- Invests in
- Europe
Last checked 19 November 2026
Industries
- Biotech
Latest deal
November 2026
News releases on portfolio milestones (Enterprise Therapeutics EMA designation, Noema Pharma FDA designation)
SourceWork at Forbion? Claim this listing to keep it up to date.
Claim this fundSomething wrong or out of date? Tell us and we'll fix it.
Report a mistakeWe list funds from public sources and check each one's website and recent activity. No guarantee of accuracy, and this is not investment advice.